CTS's 1‑year return of +51.2% versus the S&P's +27.5% is the most striking figure, demonstrating that the stock has more than doubled its relative advantage over a full market cycle, which could justify a premium valuation for its growth trajectory.
CTS’s long‑term returns, while superior, are still modest relative to high‑growth tech peers; a slowdown in defense spending or supply‑chain disruptions could trim the 10‑year CAGR from +13.9% toward the market average, eroding its valuation premium.
The -1.65% decline in institutional ownership, while small, translates to roughly $150 million of equity exiting the hands of large investors; if this trend accelerates, it could signal a shift in sentiment and increase downward pressure on price.
The recent 5.2% revenue acceleration—double the sector’s average growth—signals that CTS's strategic shift toward higher‑margin aerospace and defense contracts is beginning to bear fruit, potentially re‑accelerating top‑line momentum after years of decline.
If CTS’s gross margin slips below 35%—a 3.5‑point decline—its net income would fall by roughly $19 million (≈4% of revenue) given the current cost structure, underscoring the risk that any pricing pressure or raw‑material cost surge could materially erode profitability.
CTS’s ROE jump to 11.8%—driven by a twelve‑point margin increase while simultaneously cutting leverage—demonstrates a rare dual advantage of higher profitability and lower financial risk, positioning the company for sustainable earnings growth.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 11.8 | 12.0 | 0.71 | 1.39 | 13.7 | 12.9 | 8.5 |
| 2024 | 10.9 | 11.3 | 0.67 | 1.44 | 12.2 | 11.4 | 7.6 |
| 2023 | 11.5 | 11.0 | 0.74 | 1.41 | 13.2 | 12.3 | 8.2 |
| 2022 | 11.8 | 10.2 | 0.78 | 1.48 | 15.8 | 14.8 | 8.0 |
| 2021 | -9.0 | -8.2 | 0.77 | 1.43 | 16.2 | 14.0 | -6.3 |
| 2020 | 8.2 | 8.2 | 0.68 | 1.48 | 10.9 | 9.2 | 5.5 |
| 2019 | 8.9 | 7.7 | 0.73 | 1.59 | 13.1 | 11.0 | 5.6 |
| 2018 | 12.3 | 9.9 | 0.86 | 1.45 | 19.1 | 15.7 | 8.5 |
| 2017 | 4.2 | 3.4 | 0.79 | 1.56 | 12.5 | 10.2 | 2.7 |
| 2016 | 10.8 | 8.7 | 0.77 | 1.63 | 17.1 | 13.2 | 6.6 |
| 2015 | 2.5 | 1.8 | 0.79 | 1.72 | 10.8 | 8.1 | 1.4 |
The slight decline in asset turnover to 0.71 signals a potential slowdown in revenue generation per asset; if sales growth does not accelerate, this could erode ROIC over time despite current margin strength.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 515 | 58 | 59 | 76 | 53 | 64 |
| 2024 | 542 | 60 | 55 | 83 | 48 | 67 |
| 2023 | 491 | 60 | 52 | 79 | 44 | 69 |
| 2022 | 466 | 60 | 57 | 75 | 51 | 65 |
| 2021 | 473 | 55 | 58 | 84 | 61 | 52 |
| 2020 | 539 | 59 | 70 | 104 | 65 | 64 |
| 2019 | 501 | 49 | 61 | 101 | 56 | 54 |
| 2018 | 426 | 53 | 62 | 77 | 63 | 51 |
| 2017 | 463 | 47 | 61 | 76 | 64 | 45 |
| 2016 | 476 | 41 | 58 | 76 | 57 | 41 |
| 2015 | 462 | 35 | 52 | 67 | 58 | 30 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $764M | $213M | $552M | $122M | $40M | $82M | $253M | $110M |
| 2024 | $766M | $235M | $531M | $117M | $23M | $94M | $244M | $98M |
| 2023 | $741M | $214M | $527M | $97M | $-67M | $164M | $319M | $97M |
| 2022 | $748M | $242M | $506M | $109M | $-48M | $157M | $326M | $113M |
| 2021 | $664M | $201M | $464M | $75M | $-67M | $141M | $289M | $114M |
| 2020 | $626M | $202M | $424M | $81M | $-11M | $92M | $233M | $105M |
| 2019 | $643M | $238M | $405M | $127M | $27M | $100M | $237M | $97M |
| 2018 | $548M | $170M | $378M | $50M | $-51M | $101M | $239M | $104M |
| 2017 | $538M | $194M | $344M | $76M | $-37M | $114M | $234M | $102M |
| 2016 | $518M | $200M | $318M | $90M | $-24M | $114M | $216M | $98M |
| 2015 | $484M | $202M | $282M | $91M | $-66M | $157M | $252M | $101M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $102M | $-19M | $-98M | $-16M | $86M | $-56M | $-5M |
| 2024 | $99M | $-141M | $-28M | $-19M | $81M | $-43M | $-5M |
| 2023 | $89M | $-18M | $-65M | $-15M | $74M | $-41M | $-5M |
| 2022 | $121M | $-111M | $4M | $-14M | $107M | $-21M | $-5M |
| 2021 | $86M | $-16M | $-21M | $-16M | $70M | $-9M | $-5M |
| 2020 | $77M | $-23M | $-61M | $-15M | $62M | $-8M | $-5M |
| 2019 | $64M | $-96M | $30M | $-22M | $43M | $-12M | $-5M |
| 2018 | $58M | $-28M | $-42M | $-28M | $30M | $-9M | $-5M |
| 2017 | $58M | $-37M | $-21M | $-18M | $40M | $-2M | $-5M |
| 2016 | $47M | $-81M | $-9M | $-20M | $27M | $-2M | $-5M |
| 2015 | $39M | $-9M | $-7M | $-10M | $29M | $-18M | $-5M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net